Ratings
0
Nobody has rated this yet. Be the first!
Works
19
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Shared heritability and functional enrichment across six solid cancers
Integrative kinome profiling identifies mTORC1/2 inhibition as treatment strategy in ovarian clear cell carcinoma.
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.
Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas
